|
|
|
| home > white papers > R&D to Product: How to Reduce Costly Scale-Up Problems - Natoli Engineering Company, Inc. |
|
|
 WHITE PAPERS |
|
Natoli Engineering Company, Inc.
|
|
R&D to Product: How to Reduce Costly Scale-Up Problems
|
|
When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Pharmaceutical Packaging and Labelling Summit in Zurich; ACG presentation
At next week’s Pharmaceutical Packaging and Labelling Summit in Zurich (18-19 June), Dr. Eugen Hertel from ACG will be speaking on: Challenges for Global Pharma companies to Implement Anti-Counterfeit Strategy for Russian Track & Trace Regulation. This presentation will include details around ‘the fight against counterfeit medicine - there have been and still are worldwide initiatives to make the supply chain and the safety of medicines secure. After large markets such as the USA and Europe passed their laws and regulations for the pharmaceutical manufacturing companies and established the IT infrastructure, Russia is now next on the move.
More info >> |
|
 |
White Papers |
 |
|
PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance
Phlexglobal Ltd
Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >> |
|
 |
Industry Events |
 |
SCOPE Europe – Summit for Clinical Ops Executives Europe
17-18 September 2019, Barcelona, Spain
Building on the success of its long-running US-based counterpart, Summit for Clinical
Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical
innovation leaders, clin ops execs, functional heads, category managers, and those
responsible for the planning and management of clinical trials in Europe and the Rest of
the World. The event will feature opening and closing plenary keynote sessions, five
conference tracks, interactive breakout discussion groups, and networking.
It is an opportunity for leaders from large, mid-sized, and small pharma, specialty
pharma, biotech, vendor companies, and academic research centers to come together to
share best practices and discuss the new era of analytics-driven and patient-centric
trials.
More info >> |
|
|
|
